Piceatannol: A potential futuristic natural stilbene as fetal Haemoglobin inducer

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 12, 2013, Pages 3028-3031

  Kukreja, Aayush ^a   Tandon, Samarth ^a   Mishra, Amit ^a   Tiwari, Archana ^a  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Beta thalassaemia; Foetal haemoglobin inducer; Piceatannol; Stilbene

Indexed keywords

ANGELICIN; BERGAPTEN; BUTYRIC ACID; CUCURBITACIN; FRUCTUS TRICHOSANTHIS EXTRACT; HEMOGLOBIN F; HEMOGLOBIN GAMMA CHAIN; HYDROXYUREA; MITHRAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PICEATANNOL; PLANT EXTRACT; RAPAMYCIN; RESVERATROL; STILBENE; UNCLASSIFIED DRUG;

BETA THALASSEMIA; GENETICS; HEMOGLOBIN SYNTHESIS; HUMAN; NONHUMAN; REVIEW; TRITICUM AESTIVUM;

EID: 84890461821     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/6239.3839     Document Type: Review

References (46)

1. Fathallah H, Atweh GF. Induction of fetal hemoglobin in the treatment of sickle cell disease. Heamatology Am Soc Heamatol Educ Program. 2006:58-62.
2. Manca L, Masala B. Disorders of the synthesis of human fetal hemoglobin. IUBMB Life. 2008; 60(2):94-111.
3. Gabbianelli M, Testa U. Role of stem cell factor in the reactivation of human fetal hemoglobin. Mediterr J Heamatol Infect Dis. 2009; 1(1):e2009009.
4. Macari ER, Lowrey CH. Induction of human fetal hemoglobin via the NRF2 Anti-oxidant response signaling pathway. Blood. 2011;117(22):5987-97.
5. Thein SL. The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. Blood Rev. 2012; 26 (Suppl 1):S35-9.
6. Sankaran VG, Xu J, Orkin SH. Advances in the understanding of Haemoglobin switching. Br J Haematol. 2010;149(2):181-94.
7. Voon HP, Vadolas J. Controlling alpha-globin: a review of alpha-globin expression and its impact on beta-thalassemia. Haematologica. 2008; 93(12):1868-76.
8. Galanello R, Cao A. Gene test review. Alpha-thalassemia. Genet Med. 2011; 13(2):83-8.
9. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010; 5:11.
10. Bauer DE, Kamran SC, Orkin SH. Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders. Blood. 2012; 120(15):2945-53.
11. Costa FC, Fedosyuk H, Neades R, Bravo de Los Rios J, Barbas CF, Peterson KR. Induction of Fetal Hemoglobin In Vivo Mediated by a Synthetic γ-Globin Zinc Finger Activator. Anaemia. 2012; 2012: Article ID 507894.
12. Bianchi N, Zuccato C, Lampronti I, Borgatti M, Gambari R. Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of β-Thalassemia and Sickle-Cell Anemia. Evid Based Complement Alternat Med. 2009; 6(2): 141-51.
13. Kumari S, Mishra A, Tiwari A. Beta-thalassemia Treatment Passing Through Natural Fetal Heamoglobin Inducers. Journal of Pharmacy Research. 2011; 4(10):3851.
14. Fibach E, Bianchi N, Borgatti M, Prus E, Gambari R. Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells. Blood. 2003; 102(4):1276-81.
15. Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: a review of the evidence. Kidney Int. 2001 Jan;59(1):3-16.
16. Mischiati C, Sereni A, Lampronti I, Bianchi N, Borgatti M, Prus E, et al. Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells. Br J Haematol. 2004; 126(4):612-21.
17. Li H, Ko CH, Tsang SY, Leung PC, Fung MC, Fung KP. The Ethanol Extract of Fructus trichosanthis Promotes Fetal Hemoglobin Production via p38 MAPK Activation and ERK Inactivation in K562 Cells. Evidence-Based Complementary and Alternative Medicine. 2011; 2011: Article ID 657056.
18. El-Beshlawy A, Hamdy M, El Ghamrawy M. Fetal globin induction in beta-thalassemia. Heamoglobin. 2009;33 (Suppl 1):S197-203.
19. Lampronti I, Bianchi N, Borgatti M, Fibach E, Prus E, Gambari R. Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin. Eur J Haematol. 2003; 71(3):189-95.
20. Swati Padalia, Sushma Drabu, Indira Raheja, Alka Gupta, Mamta Dhamija. Multitude potential of wheatgrass juice (Green Blood): An overview. J Postgrad Med. 2010; 1(3):23-28.
21. Singh LK, Rai M, Chaudhary M. Intellectual Properties Rights-A strong determinant of economic growth in agriculture. Chronicles of Young Scientists. 2010; 1(2): 29-34.
22. Rana S, Kamboj JK, Gandhi V. Living life the natural way-Wheatgrass and Health. Functional Food in Health and Disease. 2011; 11: 444-56.
23. Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French paradox revisited. Front Pharmacol. 2012; 3:141.
24. Rodrigue CM, Arous N, Bachir D, Smith-Ravin J, Romeo PH, Galacteros F, Garel MC. Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation. Br J Haematol. 2001; 113(2):500-7.
25. Piotrowska H, Kucinska M, Murias M. Biological activity of piceatannol: leaving the shadow of resveratrol. Mutat Res. 2012; 750(1):60-82.
26. Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR. Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem. 2004; 52(15):4713-9.
27. Ha do T, Chen QC, Hung TM, Youn UJ, Ngoc TM, Thuong PT, et al. Stilbenes and oligostilbenes from leaf and stem of Vitis amurensis and their cytotoxic activity. Arch Pharm Res. 2009; 32(2):177-83.
28. Bavaresco L, Fregoni MARIO, Trevisan Mattivi F, Vrhovsek U, Falchetti R. The occurrence of the stilbene piceatannol in grapes. Vitis. 2002; 41: 133-36.
29. Lin LL, Lien CY, Cheng YC, Ku KL. An effective sample preparation approach for screening the Anti-cancer compound piceatannol using HPLC coupled with UV and fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 853(1-2):175-82.
30. Kwon JY, Seo SG, Heo YS, Yue S, Cheng JX, Lee KW, Kim KH. Piceatannol, Natural Polyphenolic Stilbene, Inhibits Adipogenesis via Modulation of Mitotic Clonal Expansion and Insulin Receptor-dependent Insulin Signaling in Early Phase of Differentiation. The Journal of Biological Chemistry. 287 (14): 11566-78.
31. Chang JK, Hsu YL, Teng IC, Kuo PL. Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production. Eur J Pharmacol. 2006;551(1-3):1-9.
32. Matsui Y, Sugiyama K, Kamei M, Takahashi T, Suzuki T, Katagata Y, Ito T. Extract of passion fruit (Passiflora edulis) seed containing high amounts of piceatannol inhibits melanogenesis and promotes collagen synthesis. J Agric Food Chem. 2010; 58: 11112-18.
33. Minakawa M, Miura Y, Yagasaki K. Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice. Biochem Biophys Res Commun. 2012; 422(3):469-75.
34. Wolter F, Clausnitzer A, Akoglu B, Stein J. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J Nutr. 2002; 132(2):298-302.
35. Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T, Ruparelia KC, Lamb JH, Farmer PB, Stanley LA, Burke MD. The cancer preventative agent resveratrol is converted to the Anti-cancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer. 2002; 86(5):774-8.
36. Okuda T, Ito H. Tannins of Constant Structure in Medicinal and Food Plants-Hydrolyzable Tannins and Polyphenols Related to Tannins. Molecules. 2011; 16(3): 2191-2217.
37. Marques FZ, Markus MA, Morris BJ. Resveratrol: cellular actions of a potent natural chemical that confers a diversity of health benefits. Int J Biochem Cell Biol. 2009; 41(11):2125-8.
38. King RE, Bomser JA, Min DB. Bioactivity of resveratrol. Comprehensive Reviews in Food Science and Food Safety. 2006; 5: 65-70.
39. Kim HJ, Lee KW, Lee HJ. Protective effects of piceatannol against beta-amyloid-induced neuronal cell death. Ann N Y Acad Sci. 2007; 1095:473-82.
40. Wesołowska O, Kuzdzał M, Strancar J, Michalak K. Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes. Biochim Biophys Acta. 2009; 1788(9):1851-60.
41. Wieder T, Prokop A, Bagci B, Essmann F, Bernicke D, Schulze-Osthoff K, et al. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukaemic lymphoblasts. Leukaemia. 2001; 15(11):1735-42.
42. Minakawa M, Miura Y, Yagasaki K. Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice. Biochem Biophys Res Commun. 2012;422(3):469-75.
43. Liu WH, Chang LS. Piceatannol induces Fas and FasL up-regulation in human leukemia U937 cells via Ca2+/p38alpha MAPK-mediated activation of c-Jun and ATF-2 pathways. Int J Biochem Cell Biol. 2010 Sep; 42(9):1498-506.
44. Liu K, Xing H, Zhang S, Liu Sm, Fung Mc. Cucurbitacin D, induces fetal hemoglobin synthesis in K562 cells and human hematopoietic progenitors through activation of p38 pathway and stabilization of the γ-globin mRNA. Blood Cells Mol Dis. 2010; 45(4):269-75.
45. Pace BS, Zein S. Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction. Dev Dyn. 2006; 235(7):1727-37.
46. Liu WH, Chang LS. Suppression of Akt/Foxp3-mediated miR-183 expression blocks Sp1-mediated ADAM17 expression and TNFα-mediated NFκB activation in piceatannol-treated human leukemia U937 cells. Biochem Pharmacol. 2012; 84(5):670-80.